Advertisement

Topics

Rational Therapeutics, Inc Company Profile

05:18 EDT 20th September 2018 | BioPortfolio

Who are we?
Rational Therapeutics, Inc. (RTI) is a free-standing research laboratory located in Long Beach, CA. Founded in 1993 by Dr. Robert Nagourney, a prominent hematologist/oncologist, Rational Therapeutics pioneers intelligent cancer therapies that are scientifically tailored for each individual patient.

What do we do?

Rational Therapeutics develops and provides cancer therapy recommendations, which have been designed specifically for each patient. Following the collection of living cancer cells obtained at the time of biopsy or surgery, Rational Therapeutics performs an EVA™ (Ex-Vivo Assay) on your tumor sample to measure drug activity (sensitivity and resistance). This will determine exactly which drug(s) will be most effective for YOU. We then make our treatment recommendation. The treatment program developed through this approach is known as "assay-directed therapy."

Location

750 East 29th St.
Long Beach
California
90806
United States of America

Contact

Phone: (562) 989-6455
Fax: (562) 989-8160
Email: client.services@rationaltherapeutics.com


News Articles [770 Associated News Articles listed on BioPortfolio]

Rational addiction and Naloxone

Suppose for a moment that addicts are rational and that we’re really in a Becker-Murphy world. What happens in that world if a new technology makes it safer to consume an addictive product? If y...

FDA Launches Criminal Investigation into Rational Vaccines Over Unauthorized Herpes Research

One month after three patients who developed adverse reactions following injections of an unauthorized herpes vaccine filed a lawsuit against Rational Vaccines, the U.S. Food and Drug Administration h...

Roche: Stefan Frings. Developing personalised cancer care through rational integration of diagnostics and therapeutics

In this episode of PharmaTelevision News Review, filmed at Bio Conference 2013, in Chicago, USA, Fintan Walton talks to Stefan Frings.

Rational quantum secret sharing

Rational design of zeolite catalysts

Rational Combinations 360° Summit Confirms Program Line-Up for September 13-14, 2018

The 3rd annual Rational Combinations 360°, organized by the Conference Forum, presents a two day agenda providing the most up-to-date research, data and progress to help IO stakeholders fight a w...

A universal principle for a rational design of single-atom electrocatalysts

T cells in coeliac disease: a rational target for diagnosis and therapy

PubMed Articles [556 Associated PubMed Articles listed on BioPortfolio]

Does knowing that a suicide was "rational" influence grief?

Counseling professionals and graduate students (N = 117) recruited online read a randomly assigned one-paragraph vignette about either a non-rational or rational suicide involving an imaginary lov...

Towards rationally designed biomanufacturing of therapeutic extracellular vesicles: impact of the bioproduction microenvironment.

Extracellular vesicles (EVs), including exosomes, microvesicles, and others, have emerged as potential therapeutics for a variety of applications. Pre-clinical reports of EV efficacy in treatment of n...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Brief Report: Risk-Aversion and Rationality in Autism Spectrum Disorders.

Risk-aversion and rationality have both been highlighted as core features of decision making in individuals with Autism Spectrum Disorders (ASD). This study tested whether risk-aversion is related to ...

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Clinical Trials [302 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1304 Associated Companies listed on BioPortfolio]

Rational Therapeutics, Inc

Who are we?Rational Therapeutics, Inc. (RTI) is a free-standing research laboratory located in Long Beach, CA. Founded in 1993 by Dr. Robert Nagourney, a prominent hematologist/oncologist, Rational Th...

Paradigm Therapeutics Incorporated

Paradigm Therapeutics is an emerging drug discovery company focussed on the pharmaceutical exploitation of the human genome. The race to define biological function of the thousands of uncharacterised ...

GlycoMimetics, Inc. (GMI)

GlycoMimetics is a privately held biotechnology company that capitalizes on advances in the field of glycobiology. The company uses rational design of small molecule drugs that mi...

GlycoMimetics, Inc.

GlycoMimetics is a privately held biotechnology company that capitalizes on advances in the field of glycobiology. The company uses rational design of small molecule drugs that mi...

Numab Therapeutics AG

Founded in 2011, Numab develops a proprietary pipeline of multi-specific biotherapeutics in immuno-oncology and immunology, and has a number of discovery partnerships with pharmac...

More Information about "Rational Therapeutics, Inc" on BioPortfolio

We have published hundreds of Rational Therapeutics, Inc news stories on BioPortfolio along with dozens of Rational Therapeutics, Inc Clinical Trials and PubMed Articles about Rational Therapeutics, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rational Therapeutics, Inc Companies in our database. You can also find out about relevant Rational Therapeutics, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record